Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Circulating Cell-free Genome Atlas project Resource Report Resource Website |
Circulating Cell-free Genome Atlas project (RRID:SCR_023878) | CCGA | data or information resource, portal, project portal, software resource, source code | Prospective, observational, longitudinal, study designed to characterize landscape of genomic cancer signals in blood of people with and without cancer. Sudy includes people in the USA and Canada who had cancer at the time of enrollment, newly diagnosed, and not yet received treatment, and people who did not have known cancer diagnosis. | genomic cancer signals, blood, genomic cancer, cancer | cancer | PMID:36400018 | Free, Freely available | https://github.com/grailbio-publications/Jamshidi_CCGA1LOD_2022 | SCR_023878 | Circulating Cell-free Genome Atlas (CCGA) | 2026-08-29 11:28:31 | 0 | ||||||
|
National Cancer Institute Cancer Statistics Cancer Stat Facts Resource Report Resource Website 1+ mentions |
National Cancer Institute Cancer Statistics Cancer Stat Facts (RRID:SCR_024437) | data or information resource | Collection of statistical summaries for number of common cancer types. They were developed to provide quick overview of frequently requested cancer statistics. Available statistics may include incidence, mortality, survival, stage, prevalence, and lifetime risk. Links to additional resources from NCI including risk factors, treatment, and clinical trials are also provided. The statistics will be updated annually to coincide with the SEER data release. | NCI, statistical summaries collection, cancer statistics, incidence, mortality, survival, stage, prevalence, lifetime risk, risk factors, treatment, clinical trials links, | cancer | Free, Available for download, Freely available | SCR_024437 | 2026-08-29 11:28:11 | 8 | ||||||||||
|
NCI Site Recode ICD-O-3/WHO 2008 Definition Resource Report Resource Website 1+ mentions |
NCI Site Recode ICD-O-3/WHO 2008 Definition (RRID:SCR_024687) | data or information resource, disease-related portal, portal, topical portal | Website describing International Classification of Diseases-Oncology codes that corresponds to different cancer sites in the Surveillance, Epidemiology, and End Results (SEER) registry. | NIH, International Classification of Diseases-Oncology codes, different cancer sites, Surveillance, Epidemiology, and End Results registry, SEER registry, | cancer | NCI | Free, Freely available | SCR_024687 | , National Cancer Institute Site Recode ICD-O-3/WHO 2008 Definition | 2026-08-29 11:28:20 | 5 | ||||||||
|
Cancer Chemoprevention Ontology Resource Report Resource Website |
Cancer Chemoprevention Ontology (RRID:SCR_006966) | CANCO | controlled vocabulary, data or information resource, ontology | A vocabulary that is able to describe and semantically interconnect the different paradigms of the cancer chemoprevention domain. | owl | is listed by: BioPortal | Cancer | nlx_157350 | SCR_006966 | 2026-08-29 11:22:48 | 0 | ||||||||
|
Proteomic Data Commons Resource Report Resource Website 100+ mentions |
Proteomic Data Commons (RRID:SCR_018273) | PDC | analysis service resource, data or information resource, data repository, database, production service resource, service resource, storage service resource | Portal to make cancer related proteomic datasets easily accessible to public. Facilitates multiomic integration in support of precision medicine through interoperability with other resources. Developed to advance our understanding of how proteins help to shape risk, diagnosis, development, progression, and treatment of cancer. One of several repositories within NCI Cancer Research Data Commons which enables researchers to link proteomic data with other data sets (e.g., genomic and imaging data) and to submit, collect, analyze, store, and share data throughout cancer data ecosystem. PDC provides access to highly curated and standardized biospecimen, clinical, and proteomic data, intuitive interface to filter, query, search, visualize and download data and metadata. Provides common data harmonization pipeline to uniformly analyze all PDC data and provides advanced visualization of quantitative information. Cloud based (Amazon Web Services) infrastructure facilitates interoperability with AWS based data analysis tools and platforms natively. Application programming interface (API) provides cloud-agnostic data access and allows third parties to extend functionality beyond PDC. Structured workspace that serves as private user data store and also data submission portal. Distributes controlled access data, such as patient-specific protein fasta sequence databases, with dbGaP authorization and eRA Commons authentication. | Cancer, proteomic, data, precision medicine, diagnosis, treatment, analysis, biospeciment, clinical data, metadata |
is related to: Cancer Research Data Commons has parent organization: National Cancer Institute |
cancer | Restricted | SCR_018273 | 2026-08-29 11:26:04 | 102 | ||||||||
|
NCI Imaging Data Commons Resource Report Resource Website 1+ mentions |
NCI Imaging Data Commons (RRID:SCR_019127) | NCI IDC | data or information resource, data repository, disease-related portal, portal, service resource, storage service resource, topical portal | Portal for finding and analyzing cancer imaging data. Part of Cancer Research Data Commons to support cancer imaging research. Provides cloud based access to medical imaging data and library of analytical tools and workflows to share, analyze, and visualize multi modal imaging data from both clinical and basic cancer research studies. | Imaging Data Commons Data, cloud based data analysis, FAIR data, cancer imaging data, metadata |
uses: DICOM standard is related to: FAIRsharing is related to: Cancer Imaging Archive (TCIA) is related to: Cancer Research Data Commons |
Cancer | NIH | Free, Freely available | r3d100014074 | https://doi.org/10.17616/R31NJNCQ | SCR_019127 | National Cancer Institute Imaging Data Commons | 2026-08-29 11:25:57 | 9 | ||||
|
Cancer Research Data Commons Resource Report Resource Website 10+ mentions |
Cancer Research Data Commons (RRID:SCR_019128) | CRDC | data or information resource, data repository, disease-related portal, portal, service resource, storage service resource, topical portal | Cloud based data science infrastructure that provides secure access to cancer research data from NCI programs and key external cancer programs. Serves as coordinated resource for public data sharing of NCI funded programs. Users can explore and use analytical and visualization tools for data analysis. Enables to search and aggregate data across repositories including Cancer Data Service, Clinical Trial Data Commons, Genomic Data Commons, Imaging Data Commons, Integrated Canine Data Commons, Proteomic Data Commons. |
is related to: NCI Imaging Data Commons is related to: FAIRsharing is related to: The Cancer Genome Atlas is related to: Cancer Cell Line Encyclopedia is related to: Genomic Data Commons Data Portal (GDC Data Portal) is related to: Proteomic Data Commons |
Cancer | NIH | Restricted | SCR_019128 | NCI Cancer Research Data Commons, NCI CRDC | 2026-08-29 11:26:19 | 13 | |||||||
|
Cancer Cell Map Initiative Resource Report Resource Website |
Cancer Cell Map Initiative (RRID:SCR_023043) | CCMI | data or information resource, disease-related portal, portal, topical portal | Initiative to enable cancer discovery and treatment based on complete elucidation of molecular networks underlying cancer. CCMI leverages advanced interaction mapping and computational facilities to generate and analyze cancer networks. | Enable cancer discovery and treatment, molecular networks underlying cancer, interaction mapping, computational facilities, generate and analyze cancer networks | cancer | Free, Freely available | SCR_023043 | 2026-08-29 11:27:52 | 0 | |||||||||
|
caHUB Resource Report Resource Website |
caHUB (RRID:SCR_009657) | caHUB | data or information resource, narrative resource, standard specification | THIS RESOURCE IS NO LONGER IN SERVICE. Documented July 5, 2018. A national center for biospecimen science and standards to advance cancer research and treatment. It was created in response to the critical and growing need for high-quality, well-documented biospecimens for cancer research. The initiative builds on resources already developed by the NCI, including the Biospecimen Research Network and the NCI Best Practices for Biospecimen Resources, both of which were developed to address challenges around standardization of the collection and dissemination of quality biospecimens. caHUB will develop the infrastructure for collaborative biospecimen research and the production of evidence-based biospecimen standard operating procedures. | biospecimen, clinical, biomaterial supply resource, tissue |
is listed by: NIDDK Information Network (dkNET) is related to: Biorepositories and Biospecimens Research Branch has parent organization: National Cancer Institute |
Cancer | NCI ; ARRA |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156094 | SCR_009657 | The Cancer Human Biobank, cancer Human Biobank | 2026-08-29 11:28:14 | 0 | |||||
|
LINCS Project Resource Report Resource Website 50+ mentions |
LINCS Project (RRID:SCR_016486) | LINCS | consortium, data or information resource, database, organization portal, portal, project portal | Project to create network based understanding of biology by cataloging changes in gene expression and other cellular processes when cells are exposed to genetic and environmental stressors. Program to develop therapies that might restore pathways and networks to their normal states. Has LINCS Data Coordination and Integration Center and six Data and Signature Generation Centers: Drug Toxicity Signature Generation Center, HMS LINCS Center, LINCS Center for Transcriptomics, LINCS Proteomic Characterization Center for Signaling and Epigenetics, MEP LINCS Center, and NeuroLINCS Center. | data integration, network biology, gene expression, L1000, MCF10A, MEMA, P100, LINCS program, LINCS project, systems biology, systems pharmacology, FASEB list |
is related to: Drug Gene Budger is related to: LINCS Joint Project - Breast Cancer Network Browser is related to: piNET |
cancer, heart disease, neurodegenerative disorder | NHGRI U54 HG008097; NHGRI U54 HG008098; NHGRI U54 HG008100; NHLBI U54 HL127365; NHLBI U54 HL127366; NHLBI U54 HL127624; NIH Common Fund ; NINDS U54 NS091046 |
PMID:29199020 | Free, Freely available | SCR_016487 | SCR_016486 | LINCS, Library of Integrated Network based Cellular Signatures, LINCS Program | 2026-08-29 11:25:46 | 56 | ||||
|
CaTCh FISH Chip Resource Report Resource Website 1+ mentions Rating or validation data |
CaTCh FISH Chip (RRID:SCR_015810) | resource | Equipment that is a magnetic micropore chip for rapid unbiased circulating tumor cell isolation and in situ RNA analysis. The chip detects tumor cells and can help doctors treat patients with these tumors. | hardware, instrument, equipment, magnetic micropore, micropore chip, tumor cell isolation, rna analysis, in situ, microtechnology, microchip, bioengineering | Pancreatic cancer, cancer | PMID:28809985 | Commercially available | SCR_015810 | 2026-08-29 11:25:22 | 1 | |||||||||
|
MEDINA Foundation Resource Report Resource Website 1+ mentions |
MEDINA Foundation (RRID:SCR_004079) | MEDINA | data or information resource, organization portal, portal, service resource | A non-profit research center established through a public-private alliance between the Regional government of Andalusia, the pharmaceutical company Merck Sharp & Dohme Spain S.A. (MSD), and the University of Granada, that is focused on: # Discovery of new compounds and therapies as new leads for drug development # Contract Research Services: High throughput screening services for lead discovery, ADME/TOX, bioanalysis and metabolomics MEDINA offers 1) natural products screening services for lead discovery on therapeutic targets developed by the customers and 2) compound profiling services for their drug candidates, using a counterscreening panel designed to determine potential risks in cardiovascular safety and drug-drug interactions. | high throughput screening, bioanalysis, metabolomics, medicine, drug candidate, drug, drug discovery, natural product, oncology, neurodegeneration |
is related to: European Gram Negative AntiBacterial Engine has parent organization: Merck has parent organization: University of Granada; Granada; Spain |
Infectious disease, Parasitic disease, Cancer | nlx_158529 | SCR_004079 | Fundaci��n MEDINA (Centro de Excelencia en Investigaci��n de Medicamentos Innovadores en Andalucia), Fundacion MEDINA, Fundaci��n Centro de Excelencia en Investigaci��n de Medicamentos Innovadores en Andaluc��a Medina, Fundaci��n MEDINA | 2026-08-29 11:28:41 | 6 | |||||||
|
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource Resource Report Resource Website 1+ mentions |
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource (RRID:SCR_004626) | HCC Tissue Biorepository | biomaterial supply resource, cell repository, material resource | The Hollings Cancer Center Tissue Biorepository & Research Pathology Services Shared Resource provides investigators with a centralized infrastructure that promotes biomedical research involving the use and study of human biospecimens. The shared resource is comprised of four integrated components: Biospecimens and data bank, Laser Capture Microdissection, Tissue Microarray, and Research Pathology Services. These components, along with extensive staff expertise, offer a comprehensive means by which researchers can utilize valuable human biospecimens and cutting edge technology to support basic, translational and clinical research. Services: * Biospecimen and Data Bank ** Collecting, processing, and banking of tissue, saliva, urine, blood, plasma, serum, and other tissue derivatives; including those for protocol driven studies ** Retrieval of banked specimens linked to clinicopathologic data, while maintaining patient confidentiality, for research use ** Quality control of collected tissue by the Tissue Biorepository Director, a trained pathologist: verification of diseased state and assessment of tumor purity, etc ** Quality control of DNA/RNA/protein isolated from collected tissue using the Agilent Bioanalyzer * Laser Capture Microdissection ** Identification, localization, and microdissection of targeted cell populations (from human and animal tissue sources) ** Extraction of DNA/RNA/protein from microdissected samples. ** Quality analysis and quality control of isolated nucleic acid using Agilent Bioanalyzer * Tissue Microarray ** Create custom and standard TMAs ** Consultation and technical support in the construction and analyses of TMA * Research Pathology Services ** Macrodissection of tissue prior to isolation of DNA/RNA/protein to increase tumor purity ** Immunohistochemistry and In-situ hybridization ** Quantitative image analysis on conventional and TMA sections, including tissue scoring, Ki-67 labeling index, microvascular density counting, and tissue microarray scoring, etc. * Bio-molecular Assessment ** Cellular DNA, RNA and protein prepared by the Tissue Repository from banked specimens or any other biomolecules submitted by investigators can be qualitatively assessed by Agilent Bioanalyzer, prior to use for downstream applications such as microarray and/or qRT-PCR analysis | cancer, leukemia, lymphoma, myeloma, solid tumor, tumor, tissue, saliva, urine, blood, plasma, serum, dna, rna, protein, clinicopathologic data, immunohistochemistry, in-situ hybridization, macrodissection, tissue microarray, paraffin, frozen, oct embedded, block, h & e staining, slide, malignant, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of South Carolina; South Carolina; USA |
Cancer, Leukemia, Lymphoma, Myeloma, Solid tumor, Tumor | Public: Prices listed for HCC, MUSC, And outside MUSC. | nlx_62775 | http://hcc.musc.edu/research/sharedresources/biorepository/index.htm | SCR_004626 | Hollings Cancer Center Tissue Biorepository Research Pathology Services Shared Resource | 2026-08-29 11:28:35 | 2 | |||||
|
Zebrafish Atlas Resource Report Resource Website 1+ mentions |
Zebrafish Atlas (RRID:SCR_006722) | Zebrafish Atlas | atlas, data or information resource, reference atlas | Atlas containing 2- and 3-dimensional, anatomical reference slides of the lifespan of the zebrafish to support research and education worldwide. Hematoxylin and eosin histological slides, at various points in the lifespan of the zebrafish, have been scanned at 40x resolution and are available through a virtual slide viewer. 3D models of the organs are reconstructed from plastic tissue sections of embryo and larvae. The size of the zebrafish, which allows sections to fall conveniently within the dimensions of the common 1 x 3 glass slide, makes it possible for this anatomical atlas to become as high resolution as for any vertebrate. That resolution, together with the integration of histology and organ anatomy, will create unique opportunities for comparisons with both smaller and larger model systems that each have their own strengths in research and educational value. The atlas team is working to allow the site to function as a scaffold for collaborative research and educational activity across disciplines and model organisms. The Zebrafish Atlas was created to answer a community call for a comprehensive, web-based, anatomical and pathological atlas of the zebrafish, which has become one of the most widely used vertebrate animal models globally. The experimental strengths of zebrafish as a model system have made it useful for a wide range of investigations addressing the missions of the NIH and NSF. The Zebrafish Atlas provides reference slides for virtual microscopic viewing of the zebrafish using an Internet browser. Virtual slide technology allows the user to choose their own field of view and magnification, and to consult labeled histological sections of zebrafish. We are planning to include a complete set of embryos, larvae, juveniles, and adults from approximately 25 different ages. Future work will also include a variety of comparisons (e.g. normal vs. mutant, normal vs. diseased, multiple stages of development, zebrafish with other organisms, and different types of cancer)., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | embryo, eosin, expression, genetic, adult, anatomical, anatomy, cancer, development, hematoxylin, histological, histology, juvenile, larvae, lifespan, model, slide, sagittal, coronal, transverse, stage, embryonic zebrafish, juvenile zebrafish, immature zebrafish, larval zebrafish, young zebrafish, adult zebrafish | has parent organization: Pennsylvania State University | Normal, Mutant, Cancer | NCRR | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-24352 | SCR_006722 | Penn State Zebrafish Atlas, Zebrafish Atlas - A Lifespan Atlas of the Zebrafish, PSU Zebrafish Atlas | 2026-08-29 11:28:44 | 3 | |||||
|
JP McCarthy Cord Stem Cell Bank Resource Report Resource Website |
JP McCarthy Cord Stem Cell Bank (RRID:SCR_004540) | J.P. McCarthy Cord Stem Cell Bank | biomaterial supply resource, cell repository, material resource | The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute is a public, non-profit stem cell bank with over 1,200 umbilical cord blood units in its inventory. The bank was founded in 2001 and is one of only 21 internationally recognized cord stem cell banks affiliated with the National Marrow Donor Program. The only bank of its kind in Michigan, it was created in anticipation of providing life-saving hope to people who have been diagnosed with cancer and serious blood disorders. Karmanos collects, processes and stores donated umbilical cord blood that becomes a readily available source of hematopoietic stem cells for transplant in children and adults with leukemia, lymphoma, sickle cell disease or other life-threatening conditions. The J.P. McCarthy Cord Blood Bank and Carls Processing Laboratory is also accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The accreditation signifies the highest standards of practice in collection, processing and transplantation. Karmanos is the only FACT accredited cord blood bank in Michigan and one of only nine in the United States. In the Detroit Metropolitan area, the number of hospitals participating in the collection of cord blood is rapidly increasing. Please consider donating your baby''s cord blood if you are delivering at one of our participating hospitals: Henry Ford Wyandotte Hospital in Wyandotte, MI, Providence Park Hospital in Novi, MI, St. Joseph Mercy Hospital in Ann Arbor | stem cell |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Karmanos Cancer Institute |
Cancer, Blood disorder, Leukemia, Lymphoma, Sickle cell disease, Life-threatening condition | J.P. McCarthy Fund ; Carls Foundation |
nlx_53223 | http://www.karmanos.org/app.asp?id=1142 | SCR_004540 | J.P. McCarthy Cord Stem Cell Bank | 2026-08-29 11:28:41 | 0 | |||||
|
Intramural Research Program Resource Report Resource Website 500+ mentions |
Intramural Research Program (RRID:SCR_012734) | NIA IRP | data or information resource, organization portal, portal | A research program of the NIA which focuses on neuroscience, aging biology, and translational gerontology. The central focus of the program's research is understanding age-related changes in physiology and the ability to adapt to environmental stress, and using that understanding to develop insight about the pathophysiology of age-related diseases. The IRP webpage provides access to other NIH resources such as the Biological Biochemical Image Database, the Bioinformatics Portal, and the Baltimore Longitudinal Study of Aging., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | endocrinology, epidemiology, genetics, behavioral science, biochemistry, biomedical, cancer, cardiology, cell biology, clinical research, cognition, collaboration, gerontology, healthy, hematology, human, immunology, molecular biology, neurobiology, neurogenetics, neuroscience, oncology, osteoarthritis, pathophysiology, physiology, psychology, psychophysiology, research, rheumatology, age-related disease, healthy aging, alzheimer's disease, parkinson's disease, stroke, atherosclerosis, osteoarthritis, diabetes, cancer |
has parent organization: National Institute on Aging is parent organization of: NIA Mouse cDNA Project Home Page is parent organization of: Biological Biochemical Image Database is parent organization of: GERON is parent organization of: Baltimore Longitudinal Study of Aging (BLSA) |
Aging, Age-related disease, Healthy aging, Alzheimer's disease, Parkinson's disease, Atherosclerosis, Osteoarthritis, Cancer, Diabetes, Stroke | NIA | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-09468 | SCR_012734 | National Institute on Aging Intramural Research Program, Intramural Research Program in the NIA, Intramural Research Program in the National Institute on Aging, NIA Intramural Research Program, Intramural Research Program of the National Institute on Aging | 2026-08-29 11:28:42 | 919 | |||||
|
Target genes of Wnt/beta-catenin signaling Resource Report Resource Website 10+ mentions |
Target genes of Wnt/beta-catenin signaling (RRID:SCR_007022) | Target genes of Wnt/beta-catenin signaling | data or information resource, data set | A list of target genes of Wnt/beta-catenin signaling. Suggestions for additions are welcome. Direct targets are defined as those with Tcf binding sites and demonstrating that these sites are important. | target gene, wnt/beta-catenin signaling, wnt, beta-catenin, signaling, gene | has parent organization: Stanford University; Stanford; California | Colon cancer, Tumor, Adenocarcinoma, Melanoma, Cancer | The community can contribute to this resource | nlx_156867 | SCR_007022 | 2026-08-29 11:32:07 | 24 | |||||||
|
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology Resource Report Resource Website |
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology (RRID:SCR_005957) | Biobanks of the Department of Clinical Pathology and Cytology | instrument supplier, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 6th, 2022. The biobank comprises paraffin blocks of surgical and autopsy tissue samples and corresponding histological slides as well as cytological material consisting of slides of vaginal smears, fine needle aspiration biopsies and exfoliative cytological material. The tissue samples date back until 1944 and most of the cytological samples until 1970. A subunit of the bank constitutes the National Tissue Microarray Centre. This center is supported by SWEGENE with the purpose to organize and construct tissue microarrays (TMA:s) for high throughput molecular pathology research on various kinds of tumors and other diseases. By linking the TMA.s to long-term and complete clinical follow-up data, prognostic and predictive studies will be facilitated. Biobank content: * Approximately 2,4 million paraffin blocks of surgical tissue specimens, * 1,1 million paraffin blocks of tissue samples from autopsies, * 3,8 million histological slides and * 1,6 million cytology slides. At present, the Tissue Microarray Centre includes: * A consecutive series of all invasive breast cancers (n=600) diagnosed in Malmo between 1988 and 1992. * All incident breast cancers within the Malmo Diet and Cancer cohort (n=400). * A subgroup of 600 pre-menopausal primary breast cancers within the nationwide, population-based randomized tamoxifen trial SBII:2. * 180 primary breast cancers from post-menopausal women included in a similar study. * A set of 120 extremely well characterized primary breast cancer samples with a clinical follow-up of 10 years. More than 40 relevant tumor biological parameters have been recorded in this material and it is therefore useful for a first screening of a marker in order to identify associations to other gene products. * 350 renal cell carcinomas (In collaboration with NUS). We provide researchers with state-of-the-art population based tissue microarrays with long-term and complete follow-up data on survival and treatment. With the TMA-technology, valuable biobank material will be preserved, allowing high throughput in-situ analyses of various tumors and other diseases with a minimal waste of tissue. | surgery, autopsy, histology slide, vaginal smear, fine needle aspiration, biopsy, tissue microarray, tumor, disease, cancer, diet, renal cell, kidney |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Swedish National Biobank Program |
Breast cancer, Cancer, Tumor, Carcinoma | SWEGENE | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_151315 | SCR_005957 | UMAS University Hospital - Biobanks of the Department of Clinical Pathology Cytology | 2026-08-29 11:32:03 | 0 | |||||
|
Richard M. Lucas Center for Imaging Resource Report Resource Website 1+ mentions |
Richard M. Lucas Center for Imaging (RRID:SCR_001406) | Lucas Center, CAMRT | biomedical technology research center, training resource | Biomedical technology research center that develops innovative technologies in five core research areas of magnetic resonance imaging and spectroscopy (MRI/MRS): # image reconstruction, fast imaging and radiofrequency (RF) pulse design methods, # R hardware development, # body imaging methods, # neuroimaging methods. # MR spectroscopy methods. In each of these areas, they capitalize on the long-standing, successful partnership and extensive experience in Stanford's Radiology and Electrical Engineering departments to improve and expand imaging technology for use in basic research and clinical care, and to provide cutting edge opportunities to the extramural community for biomedical research with MRI. Over its more than 18 years of existence, CAMRT has been motivated by and has served a wide base of extramurally sponsored collaborators and service users from leading medical and research institutions. Examples of collaborative projects are the development of real-time functional MRI biofeedback methods for neuroscience and clinical applications such as pain remediation, development of methods to mitigate metal artifacts in musculoskeletal imaging, development of novel RF pulses for many applications, and studies of breast cancer with efficient MRS methods. | magnetic resonance imaging, spectroscopy, x-ray imaging, ct imaging, imaging, neuroimaging | has parent organization: Stanford University School of Medicine; California; USA | Brain disorder, Cancer, Stroke, Heart disease | NIBIB | Free, Freely Available | nlx_152629 | http://med.stanford.edu/rsl/about/lucas.html | SCR_001406 | Lucas Center for Imaging, Center for Advanced Magnetic Resonance Technology | 2026-08-29 11:31:46 | 1 | ||||
|
Biomedical Simulations Resource Resource Report Resource Website 1+ mentions |
Biomedical Simulations Resource (RRID:SCR_001952) | BMSR | biomedical technology resource center, training resource | Biomedical technology resource center dedicated to the advancement of the state-of-the-art in biomedical modeling and simulation through Core and Collaborative Research projects, as well as the dissemination of this knowledge and related software through Service, Training and Dissemination activities aimed at the biomedical community at large. The BMSR includes four core research projects: * Pharmacokinetic/Pharmacodynamic Systems Analysis * Nonlinear Modeling of Complex Biomedical Systems * Modeling of Autonomic, Metabolic and Vascular Control Interactions * Nonlinear Modeling of the Hippocampus Fifteen Collaborative Research Projects serve as challenging test grounds for the Resource's methodologies and expertise. | hippocampus, modeling, simulation, model, pharmacokinetic, pharmacodynamic, systems analysis, nonlinear modeling, complex biomedical system, autonomic, metabolic, vascular control, interaction, intracellular signalling, biomarker |
has parent organization: University of Southern California; Los Angeles; USA is parent organization of: BMSR Workshops is parent organization of: BMSR Short Courses is parent organization of: LYSIS is parent organization of: PNEUMA is parent organization of: TARGETgene is parent organization of: EONS is parent organization of: ADAPT |
Cancer, Alzheimer's disease, Metabolic syndrome | NIBIB P41-EB001978 | nif-0000-10530 | http://bmsr.usc.edu/index.html | SCR_001952 | Biomedical Simulations Resource (BMSR) | 2026-08-29 11:31:47 | 8 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.